Cancer patients don't trust docs: survey

Share this article:
A survey of patients at Harvard's Dana-Farber Cancer Institute found that 11% said ads for cancer-related drugs had made them less confident in their providers' judgment.

Of the 348 respondents to the survey, in the Journal of Clinical Oncology, 86% were aware of DTC advertising, particularly TV spots (77%), with little variation across clinical or sociodemographic factors except that patients were more likely to be aware of products specific to their cancer types. Of those aware of ads, 17.3% said they'd talked to their healthcare provider about an advertised medication. Patient perceptions of DTC ads were favorable, particularly among non-college graduates.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.